前列腺癌
聚ADP核糖聚合酶
PARP抑制剂
临床试验
医学
肿瘤科
内科学
前列腺
癌症
癌症研究
生物
遗传学
DNA
聚合酶
作者
Juliet Carmichael,Ines Figueiredo,Bora Gürel,Nick Beije,Wei Yuan,Jan Rekowski,George Seed,Suzanne Carreira,Cláudia Bertan,Maria D. Fenor de la Maza,Khobe Chandran,Antje Neeb,Jon Welti,Lewis Gallagher,Denisa Bogdan,Mateus Crespo,Ruth Riisnaes,Ana Ferreira,Susana Miranda,Jinqiu Lu
摘要
BACKGROUND. Clinical trials have suggested antitumor activity from PARP inhibition beyond homologous recombination deficiency (HRD). RNASEH2B loss is unrelated to HRD and preclinically sensitizes to PARP inhibition. The current study reports on RNASEH2B protein loss in advanced prostate cancer and its association with RB1 protein loss, clinical outcome and clonal dynamics during treatment with PARP inhibition in a prospective clinical trial.
科研通智能强力驱动
Strongly Powered by AbleSci AI
PDF的下载单位、IP信息已删除
(2025-6-4)
水煮电吹风
Kao
GingerF
唠叨的大门
Criminology34
无极微光
OK
v0id
渡人舟
学术文献互助
YifanWang
null
Nole
潇洒的惋清
秋风
掐钰
zjh33
罗Eason
乌鱼
skearthy
皖公网安备34019202002308
